Cargando…
Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
BACKGROUND: Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. METHODS:...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314002/ https://www.ncbi.nlm.nih.gov/pubmed/35898389 http://dx.doi.org/10.1155/2022/8493479 |
_version_ | 1784754213363908608 |
---|---|
author | Kaaroud, Hayet Harzallah, Amel Hajji, Mariem Chargui, Soumaya Barbouch, Samia Turki, Sami Trabelsi, Raja Goucha, Rim Ben Moussa, Fatma Ben Maiz, Hedi Ben Hamida, Fethi Abderrahim, Ezzeddine |
author_facet | Kaaroud, Hayet Harzallah, Amel Hajji, Mariem Chargui, Soumaya Barbouch, Samia Turki, Sami Trabelsi, Raja Goucha, Rim Ben Moussa, Fatma Ben Maiz, Hedi Ben Hamida, Fethi Abderrahim, Ezzeddine |
author_sort | Kaaroud, Hayet |
collection | PubMed |
description | BACKGROUND: Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. METHODS: In a retrospective study carried out between 1975 and 2019, 310 cases of histologically proven and typed renal amyloidosis were selected for this study. RESULTS: There were 209 men and 101 women with a mean age of 53.8 ± 15.4 years (range, 17–84 years). Of the 310 cases, 255 (82.3%) were diagnosed with AA renal amyloidosis and 55 (17.7%) with non-AA amyloidosis. Infections were the main cause of AA amyloidosis, and tuberculosis was the most frequent etiology. The period from the onset of the underlying disease to diagnosis of the renal amyloidosis was an average of 177 months. The most frequent manifestations at the time of diagnosis were nephrotic syndrome (84%), chronic renal failure (30.3%), and end-stage renal disease (37.8%). After a medium follow-up of 16 months (range, 0–68 months), mortality occurred in 60 cases. CONCLUSIONS: Given the high frequency of AA amyloidosis in our country, awareness of the proper management of infectious and chronic inflammatory diseases remains a priority in reducing the occurrence of this serious disease. |
format | Online Article Text |
id | pubmed-9314002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-93140022022-07-26 Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center Kaaroud, Hayet Harzallah, Amel Hajji, Mariem Chargui, Soumaya Barbouch, Samia Turki, Sami Trabelsi, Raja Goucha, Rim Ben Moussa, Fatma Ben Maiz, Hedi Ben Hamida, Fethi Abderrahim, Ezzeddine Int J Nephrol Research Article BACKGROUND: Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. METHODS: In a retrospective study carried out between 1975 and 2019, 310 cases of histologically proven and typed renal amyloidosis were selected for this study. RESULTS: There were 209 men and 101 women with a mean age of 53.8 ± 15.4 years (range, 17–84 years). Of the 310 cases, 255 (82.3%) were diagnosed with AA renal amyloidosis and 55 (17.7%) with non-AA amyloidosis. Infections were the main cause of AA amyloidosis, and tuberculosis was the most frequent etiology. The period from the onset of the underlying disease to diagnosis of the renal amyloidosis was an average of 177 months. The most frequent manifestations at the time of diagnosis were nephrotic syndrome (84%), chronic renal failure (30.3%), and end-stage renal disease (37.8%). After a medium follow-up of 16 months (range, 0–68 months), mortality occurred in 60 cases. CONCLUSIONS: Given the high frequency of AA amyloidosis in our country, awareness of the proper management of infectious and chronic inflammatory diseases remains a priority in reducing the occurrence of this serious disease. Hindawi 2022-07-18 /pmc/articles/PMC9314002/ /pubmed/35898389 http://dx.doi.org/10.1155/2022/8493479 Text en Copyright © 2022 Hayet Kaaroud et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kaaroud, Hayet Harzallah, Amel Hajji, Mariem Chargui, Soumaya Barbouch, Samia Turki, Sami Trabelsi, Raja Goucha, Rim Ben Moussa, Fatma Ben Maiz, Hedi Ben Hamida, Fethi Abderrahim, Ezzeddine Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center |
title | Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center |
title_full | Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center |
title_fullStr | Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center |
title_full_unstemmed | Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center |
title_short | Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center |
title_sort | renal amyloidosis: epidemiological, clinical, and laboratory profile in adults from one nephrology center |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314002/ https://www.ncbi.nlm.nih.gov/pubmed/35898389 http://dx.doi.org/10.1155/2022/8493479 |
work_keys_str_mv | AT kaaroudhayet renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT harzallahamel renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT hajjimariem renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT charguisoumaya renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT barbouchsamia renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT turkisami renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT trabelsiraja renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT goucharim renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT benmoussafatma renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT benmaizhedi renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT benhamidafethi renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter AT abderrahimezzeddine renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter |